Search - tctmd.com

Displaying 181 - 200 of 2387

Sort: Relevancy | Date

Presentation TCT 2023

TCT 381: The Clinical implementation of CYP2C19 genotyping in patients with an acute coronary syndrome: Insights from the FORCE-ACS registry

Presenter: Jaouad Azzahhafi

October 25, 2023

Presentation TCT 2023

TARGET Clinical Trial Program (Alcohol-Mediated Renal Denervation)

Presenter: David Kandzari

October 25, 2023

Presentation TCT 2023

TCT 135: Ticagrelor Coated Stent to Eliminate the Need for DAPT post-PCI

Presenter: Jared Romeo

October 25, 2023

Presentation TCT 2023

SYMAP Clinical Trial Program (Radio-Frequency Renal Denervation)

Presenter: Felix Mahfoud

October 25, 2023

Presentation TCT 2023

TCT 99: Efficacy and safety of early single direct oral anticoagulant therapy within one year after coronary stent implantation in patients with atrial fibrillation

Presenter: Taehoon Kim

October 25, 2023

Presentation TCT 2023

TCT 11: Clinical impact of dyspnea after ticagrelor treatment and the effect of switching to clopidogrel in patients with myocardial infarction

Presenter: Sang Hyun Kim

October 25, 2023

Presentation TCT 2023

SPYRAL Clinical Trial Program (Radio-Frequency Renal Denervation)

Presenter: David Kandzari

October 25, 2023

Presentation TCT 2023

RADIANCE Clinical Trial Program (Ultrasound Renal Denervation)

Presenter: Ajay Kirtane

October 25, 2023

Presentation TCT 2023

TCT 657: Aspirin versus P2Y12 inhibitor as a combination therapy with direct oral anticoagulant after coronary stent implantation in patients with atrial fibrillation (AF).

Presenter: Hyunki LEE

October 25, 2023

Presentation TCT 2023

Preclinical Science In Renal Denervation – What Is New, What Is Clinically Relevant?

Presenter: Lucas Lauder

October 25, 2023

Presentation TCT 2023

TCT 525: The Prevalence of Bleeding and Ischemic Outcomes in Patients on Triple Therapy in a Real-Practice Registry of Percutaneous Coronary Interventions

Presenter: Eva Woelders

October 25, 2023

Presentation TCT 2023

TCT 507: Association of CYP2C19*17 Carrier Status to Ischemic and Bleeding Outcomes Among Patients with Coronary Artery Disease Treated with Clopidogrel: a Meta-Analysis

Presenter: Cole Clifford

October 25, 2023

Presentation TCT 2023

TCT 244: Impact of Online Educational Series on Interventional Innovations in Blood Pressure Control

Presenter: Ron miller

October 25, 2023

Presentation TCT 2023

TCT 380: The impact of obesity on antiplatelet monotherapy for secondary prevention after percutaneous coronary intervention: A sub-study of the HOST-EXAM trial

Presenter: Minju Han

October 25, 2023

Presentation TCT 2023

TCT 42: Does Heparin-induced thrombocytopenia affect in-hospital outcomes in patients presenting with ST-segment elevation myocardial infarction? A nationwide data analysis.

Presenter: Purveshkumar Patel

October 25, 2023

Presentation TCT 2023

Long-term Management of DVTs for the Interventional Cardiologist

Presenter: Teresa Carman

October 25, 2023

News Conference News TCT 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Yael L. Maxwell

October 25, 2023

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

Presentation TCT 2023

TCT 457: Impact of Uninterrupted Versus Interrupted Oral Anticoagulation on 30-Day Outcomes in Patients Undergoing Coronary Angiography

Presenter: Ting-Yu Wang

October 25, 2023

News Conference News TCT 2023

Comparing DCBs in De Novo CAD: Drugs, Design Matter

Caitlin E. Cox

October 25, 2023

Advertisement

TCT 381: The Clinical implementation of CYP2C19 genotyping in patients with an acute coronary syndrome: Insights from the FORCE-ACS registry

TARGET Clinical Trial Program (Alcohol-Mediated Renal Denervation)

TCT 135: Ticagrelor Coated Stent to Eliminate the Need for DAPT post-PCI

SYMAP Clinical Trial Program (Radio-Frequency Renal Denervation)

TCT 99: Efficacy and safety of early single direct oral anticoagulant therapy within one year after coronary stent implantation in patients with atrial fibrillation

TCT 11: Clinical impact of dyspnea after ticagrelor treatment and the effect of switching to clopidogrel in patients with myocardial infarction

SPYRAL Clinical Trial Program (Radio-Frequency Renal Denervation)

RADIANCE Clinical Trial Program (Ultrasound Renal Denervation)

TCT 657: Aspirin versus P2Y12 inhibitor as a combination therapy with direct oral anticoagulant after coronary stent implantation in patients with atrial fibrillation (AF).

Preclinical Science In Renal Denervation – What Is New, What Is Clinically Relevant?

TCT 525: The Prevalence of Bleeding and Ischemic Outcomes in Patients on Triple Therapy in a Real-Practice Registry of Percutaneous Coronary Interventions

TCT 507: Association of CYP2C19*17 Carrier Status to Ischemic and Bleeding Outcomes Among Patients with Coronary Artery Disease Treated with Clopidogrel: a Meta-Analysis

TCT 244: Impact of Online Educational Series on Interventional Innovations in Blood Pressure Control

TCT 380: The impact of obesity on antiplatelet monotherapy for secondary prevention after percutaneous coronary intervention: A sub-study of the HOST-EXAM trial

TCT 42: Does Heparin-induced thrombocytopenia affect in-hospital outcomes in patients presenting with ST-segment elevation myocardial infarction? A nationwide data analysis.

Long-term Management of DVTs for the Interventional Cardiologist

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

TCT 457: Impact of Uninterrupted Versus Interrupted Oral Anticoagulation on 30-Day Outcomes in Patients Undergoing Coronary Angiography

Comparing DCBs in De Novo CAD: Drugs, Design Matter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content